Will Brexit spring a leak in AstraZeneca’s talent pool?
As drug pricing policies dominate pharmaceutical headlines, the threat of economic nationalism looms even larger over AstraZeneca’s R&D pipeline.
As drug pricing policies dominate pharmaceutical headlines, the threat of economic nationalism looms even larger over AstraZeneca’s R&D pipeline.
Can wearables and electronic data capture (EDC) technologies improve clinical trials and accelerate new drug approval?